Literature DB >> 17721371

Large measles outbreak at a German public school, 2006.

Ole Wichmann1, Wiebke Hellenbrand, Daniel Sagebiel, Sabine Santibanez, Gabriele Ahlemeyer, Georg Vogt, Anette Siedler, Ulrich van Treeck.   

Abstract

BACKGROUND: In 2006, a large measles outbreak (n = 614) occurred in Duisburg city, Germany, with 54% of cases aged >9 years. An investigation was launched to determine reasons for the resurgence of measles, assess vaccination coverage and vaccine effectiveness (VE).
METHODS: A retrospective cohort-study was undertaken at a Duisburg public school affected early in the outbreak. We distributed questionnaires to all 1250 students aged 10-21 years and abstracted vaccination records. Cases were identified according to a standard clinical case definition.
RESULTS: Questionnaires were returned by 1098 (88%) students. Vaccination records were abstracted from 859 students, of whom 820 (95.4%) had received at least one, 605 (70.4%) 2, and 39 (4.5%) no dose(s) of measles-containing vaccine (MCV). Coverage with 2 doses was higher in younger students. We identified 53 cases (attack rate = 5%). Measles-virus sequencing revealed genotype D6. After excluding students vaccinated in 2006 and those with a history of measles, the attack rate was 53% in unvaccinated students, 1.0% in students with one, and 0.4% in those with 2 MCV-doses. VE was 98.1% (95% CI: 92-100%) in students with one and 99.4% (95% CI: 97-100%) with 2 MCV-doses. Based on observed attack rates in vaccinated and unvaccinated students with vaccination records and in students without vaccination records, one-dose-coverage among all participating students was estimated at 91%.
CONCLUSIONS: VE was high. Vaccination coverage was, however, insufficient to prevent the outbreak. Immunization gaps were found especially in older students. To prevent further outbreaks and to achieve the goal of measles elimination in Germany, vaccination coverage must be increased.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721371     DOI: 10.1097/INF.0b013e318060aca1

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  31 in total

1.  Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population.

Authors:  Michiel van Boven; Mirjam Kretzschmar; Jacco Wallinga; Philip D O'Neill; Ole Wichmann; Susan Hahné
Journal:  J R Soc Interface       Date:  2010-04-14       Impact factor: 4.118

2.  The influence of migratory background and parental education on health care utilisation of children.

Authors:  Nicole Rosenkötter; Martien C J M van Dongen; Wolfgang Hellmeier; Klaus Simon; Pieter C Dagnelie
Journal:  Eur J Pediatr       Date:  2012-06-23       Impact factor: 3.183

3.  An assessment of measles vaccine effectiveness, Australia, 2006-2012.

Authors:  Alexis Pillsbury; Helen Quinn
Journal:  Western Pac Surveill Response J       Date:  2015-07-09

4.  Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation.

Authors:  Ole Wichmann; Anette Siedler; Daniel Sagebiel; Wiebke Hellenbrand; Sabine Santibanez; Annette Mankertz; Georg Vogt; Ulrich van Treeck; Gérard Krause
Journal:  Bull World Health Organ       Date:  2009-02       Impact factor: 9.408

Review 5.  [Vaccination in adults].

Authors:  D M Kieninger-Baum; F Zepp
Journal:  Internist (Berl)       Date:  2011-03       Impact factor: 0.743

6.  Vaccination status and health in children and adolescents: findings of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS).

Authors:  Roma Schmitz; Christina Poethko-Müller; Sabine Reiter; Martin Schlaud
Journal:  Dtsch Arztebl Int       Date:  2011-02-18       Impact factor: 5.594

Review 7.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

8.  Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.

Authors:  Arnaud Gagneur; Didier Pinquier; Marie Aubert; Laurent Balu; Olivier Brissaud; Loïc De Pontual; Christèle Gras Le Guen; Isabelle Hau-Rainsard; Olivier Mory; Georges Picherot; Jean-Louis Stephan; Bernard Cohen; Evelyne Caulin; Benoît Soubeyrand; Philippe Reinert
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

9.  Potent non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex.

Authors:  Aiming Sun; Jeong-Joong Yoon; Yan Yin; Andrew Prussia; Yutao Yang; Jaeki Min; Richard K Plemper; James P Snyder
Journal:  J Med Chem       Date:  2008-06-05       Impact factor: 7.446

10.  Measles Outbreak at a Privately Operated Detention Facility: Arizona, 2016.

Authors:  Heather Venkat; Graham Briggs; Shane Brady; Ken Komatsu; Clancey Hill; Jessica Leung; Manisha Patel; Eugene Livar; Chia-Ping Su; Ahmed Kassem; Sun B Sowers; Sara Mercader; Paul A Rota; Diana Elson; Evan Timme; Susan Robinson; Kathryn Fitzpatrick; Jabette Franco; Carole Hickman; Paul A Gastañaduy
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.